Weiwei Chen

703 total citations
43 papers, 445 citations indexed

About

Weiwei Chen is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Weiwei Chen has authored 43 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Weiwei Chen's work include Colorectal Cancer Surgical Treatments (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Diet and metabolism studies (4 papers). Weiwei Chen is often cited by papers focused on Colorectal Cancer Surgical Treatments (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Diet and metabolism studies (4 papers). Weiwei Chen collaborates with scholars based in China, Hong Kong and United States. Weiwei Chen's co-authors include Shaohui Tang, Yang Li, Bo Li, Chang Zou, Yan Zhang, Xin‐Yuan Guan, Cai‐Ning Zhao, Feng‐Ming Kong, Timothy Shun Man Chu and Shaowei Dong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Weiwei Chen

41 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Chen China 11 203 109 95 68 63 43 445
Danilo Figueiredo Soave Brazil 13 159 0.8× 58 0.5× 135 1.4× 72 1.1× 90 1.4× 27 473
Ayumi Niwa Japan 11 77 0.4× 156 1.4× 143 1.5× 72 1.1× 41 0.7× 31 425
Nara Lee South Korea 12 113 0.6× 52 0.5× 154 1.6× 95 1.4× 77 1.2× 51 494
Mehmet Karabulut Türkiye 15 172 0.8× 75 0.7× 127 1.3× 285 4.2× 105 1.7× 91 604
Jiayuan Chen China 14 84 0.4× 63 0.6× 87 0.9× 70 1.0× 79 1.3× 28 498
Sergio Gentilli Italy 12 139 0.7× 40 0.4× 118 1.2× 185 2.7× 87 1.4× 50 506
Xianling Liu China 10 175 0.9× 34 0.3× 148 1.6× 37 0.5× 62 1.0× 33 506
Kazumasa Mori Japan 11 86 0.4× 105 1.0× 107 1.1× 134 2.0× 66 1.0× 29 534

Countries citing papers authored by Weiwei Chen

Since Specialization
Citations

This map shows the geographic impact of Weiwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Chen more than expected).

Fields of papers citing papers by Weiwei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Chen. The network helps show where Weiwei Chen may publish in the future.

Co-authorship network of co-authors of Weiwei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Chen. A scholar is included among the top collaborators of Weiwei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Chen. Weiwei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Chen, Weiwei, et al.. (2025). Combining Cetuximab and Immunotherapy for Treating MSS/pMMR Colorectal Cancer: Current Evidence and Challenges. Technology in Cancer Research & Treatment. 24. 2244076097–2244076097. 1 indexed citations
4.
Liu, Zhichao, et al.. (2024). Pharmacological Mechanism of Chinese Medicine in Systemic Lupus Erythematosus: A Narrative Review. Chinese Journal of Integrative Medicine. 31(2). 157–169. 2 indexed citations
5.
Chen, Ying, Hong Yang, Jie Song, et al.. (2024). Associations of modifiable factors with risk of irritable bowel syndrome. Frontiers in Nutrition. 11. 1362615–1362615. 3 indexed citations
6.
Peng, Xiaojuan, Sisi Chen, Lu Zhong, et al.. (2023). Cyclocarya paliurus leaves extracts alleviate metabolic phenotypes in Chinese T2DM patients by modulating gut microbiota and metabolites: a clinical randomized controlled trial. Frontiers in Endocrinology. 14. 1176256–1176256. 3 indexed citations
7.
Liu, Ke, Weiwei Chen, Yi Zhou, et al.. (2023). Associations between food groups and liver cancer: a systematic review and meta-analysis of observational studies. Nutrition Journal. 22(1). 30–30. 7 indexed citations
8.
Wang, Gang, et al.. (2022). Development and Internal Validation of a Nomogram-Based Model to Predict Three-Year and Five-Year Overall Survival in Patients with Stage II/III Colon Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Liu, Ke, et al.. (2022). Modifiable risk factors and incidence of gout: Estimation of population attributable fraction in the US. Seminars in Arthritis and Rheumatism. 55. 152040–152040. 13 indexed citations
10.
Chen, Weiwei, Gang Wang, Xiaokai Li, et al.. (2022). The number of cycles of adjuvant chemotherapy in stage III and high-risk stage II rectal cancer: a nomogram and recursive partitioning analysis. World Journal of Surgical Oncology. 20(1). 119–119. 2 indexed citations
11.
Chen, Weiwei, Wei Liu, Yingze Li, et al.. (2022). Deciphering the Immune–Tumor Interplay During Early-Stage Lung Cancer Development via Single-Cell Technology. Frontiers in Oncology. 11. 716042–716042. 5 indexed citations
12.
Chen, Weiwei, et al.. (2021). Long non-coding RNA FTX predicts a poor prognosis of human cancers: a meta-analysis. Bioscience Reports. 41(1). 10 indexed citations
13.
Guo, Liliangzi, Yuting Li, Jun Yao, et al.. (2021). Dairy Consumption and Risk of Conventional and Serrated Precursors of Colorectal Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Journal of Oncology. 2021. 1–15. 11 indexed citations
14.
Chen, Weiwei, et al.. (2021). An umbrella review of systematic reviews and meta-analyses of observational investigations of obstructive sleep apnea and health outcomes. Sleep And Breathing. 26(1). 167–188. 10 indexed citations
15.
Chen, Weiwei, et al.. (2021). Effect of the duration of the capecitabine regimen following colon cancer surgery in an elderly population: a retrospective cohort study. World Journal of Surgical Oncology. 19(1). 238–238. 5 indexed citations
16.
Li, Xiaokai, Yuxuan Xu, Yuan Yang, et al.. (2021). The Correlation Between UGT1A1 Gene Phenotypes and the Clinical Prognosis of Advanced Colorectal Cancer After FOLFIRI Therapy. Cancer Biotherapy and Radiopharmaceuticals. 36(9). 720–727. 1 indexed citations
18.
Ding, Qingqing, Hui Chen, Bora Lim, et al.. (2019). HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological features. Human Pathology. 92. 32–38. 12 indexed citations
19.
Chen, Weiwei, et al.. (2019). A One-Dimensional Hemodynamic Model of the Coronary Arterial Tree. Frontiers in Physiology. 10. 853–853. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026